Table 1

Comparison of groups with and without successful Thrombolysis in Cerebral Infarction reperfusion

TICI reperfusion (n=36)No TICI reperfusion (n=53)p Value
Age (years) (median (IQR))60.5 (50.0–73.3)68.0 (53.5–79.5)0.4
Male (n (%))18/36 (50.0)28/53 (52.8)0.8
Baseline NIHSS (median (IQR))15.0 (8.3–20.5)17.0 (12.5–19.5)0.3
Onset to catheterization time (h) (median (IQR))6.0 (4.5–8.7)5.4 (3.9–7.0)0.2
General anesthesia used (n (%))9/36 (25.0)22/53 (41.5)0.1
IV tPA used (n (%))20/36 (55.6)33/53 (62.3)0.5
Patient history (n (%))
 Atrial fibrillation14/36 (38.9)16/53 (30.2)0.5
 Hypercholesterolemia15/36 (41.2)26/53 (49.1)0.5
 Diabetes8/36 (22.2)10/53 (18.9)0.7
 Antiplatelet use9/36 (25.0)19/52 (36.5)0.3
 Anticoagulant use5/36 (13.9)5/52 (9.6)0.5
Radiographic
 Good collaterals (n (%))20/29 (69.0)11/41 (26.8)<0.001
 DWI volume (mL) (median (IQR))17.3 (8.3–42.3)19.6 (8.0–43.0)0.9
 PWI volume (mL) (median (IQR))88.9 (58.9–115.9)89.2 (44.5–135.6)0.9
 ICA occlusion (n (%))8/35 (22.9)17/47 (36.2)0.2
 M1 or M2 occlusion (n (%))27/35 (77.1)30/47 (63.8)0.2
Endovascular treatment modalities used* (n (%))
 Merci24/36 (66.7)18/53 (34.0)<0.01
 Penumbra14/36 (38.9)22/53 (41.5)0.8
 Other device14/36 (38.9)13/53 (24.5)0.2
 Intra-arterial tPA14/36 (38.9)20/53 (37.7)0.9
Hospital site† (n (%))<0.001
 A20/26 (76.9)6/26 (23.1)
 B9/24 (37.5)15/24 (62.5)
 C3/9 (33.3)6/9 (66.7)
 D2/11 (18.2)9/11 (81.8)
 E1/6 (16.7)5/6 (83.3)
 F0/5 (0.0)5/5 (100.0)
 G0/4 (0.0)4/4 (100.0)
 H0/3 (0.0)3/3 (100.0)
  • *For endovascular treatment used, percentages do not add up to 100% because multiple devices or techniques could be used per patient.

  • †Data from the ninth site are omitted as only one patient was treated at that site.

  • DWI, diffusion weighted imaging; ICA, internal carotid artery; NIHSS, National Institutes of Health Stroke Scale; PWI, perfusion weighted imaging; TICI, Thrombolysis in Cerebral Infarction; tPA, tissue plasminogen activator.